1. Home
  2. EDSA vs PASW Comparison

EDSA vs PASW Comparison

Compare EDSA & PASW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • PASW
  • Stock Information
  • Founded
  • EDSA 2015
  • PASW 2021
  • Country
  • EDSA Canada
  • PASW Hong Kong
  • Employees
  • EDSA N/A
  • PASW N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • PASW Apparel
  • Sector
  • EDSA Health Care
  • PASW Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • PASW Nasdaq
  • Market Cap
  • EDSA 18.6M
  • PASW 15.9M
  • IPO Year
  • EDSA N/A
  • PASW N/A
  • Fundamental
  • Price
  • EDSA $1.73
  • PASW $0.59
  • Analyst Decision
  • EDSA Strong Buy
  • PASW
  • Analyst Count
  • EDSA 2
  • PASW 0
  • Target Price
  • EDSA $13.00
  • PASW N/A
  • AVG Volume (30 Days)
  • EDSA 908.6K
  • PASW 69.5K
  • Earning Date
  • EDSA 12-12-2025
  • PASW 01-12-2026
  • Dividend Yield
  • EDSA N/A
  • PASW N/A
  • EPS Growth
  • EDSA N/A
  • PASW N/A
  • EPS
  • EDSA N/A
  • PASW N/A
  • Revenue
  • EDSA N/A
  • PASW $8,286,193.00
  • Revenue This Year
  • EDSA N/A
  • PASW N/A
  • Revenue Next Year
  • EDSA N/A
  • PASW N/A
  • P/E Ratio
  • EDSA N/A
  • PASW N/A
  • Revenue Growth
  • EDSA N/A
  • PASW N/A
  • 52 Week Low
  • EDSA $1.55
  • PASW $0.53
  • 52 Week High
  • EDSA $4.49
  • PASW $5.40
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 35.70
  • PASW N/A
  • Support Level
  • EDSA $1.69
  • PASW N/A
  • Resistance Level
  • EDSA $1.83
  • PASW N/A
  • Average True Range (ATR)
  • EDSA 0.15
  • PASW 0.00
  • MACD
  • EDSA -0.01
  • PASW 0.00
  • Stochastic Oscillator
  • EDSA 17.00
  • PASW 0.00

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

Share on Social Networks: